01 — At a Glance
The Health Insurance Middleman That Became A Middleman To Its Own Growth
- 52-Week High / Low₹594 / ₹295
- Q3 FY26 Revenue₹239.68 Cr
- Q3 FY26 PAT₹4.14 Cr
- TTM EPS₹7.92
- Annualised EPS (Q3 Avg × 4)₹1.12
- Book Value / Share₹77.8
- Price to Book4.18x
- PUM (Sep 2025)₹21,108 Cr
- Debt-Free StatusJan 2026
- Promoter Holding4.62%
Flash Summary: Medi Assist is living in three universes simultaneously. Universe 1: Revenue up 28.9% to ₹239.68 crore in Q3, managed ₹21,108 crore of premiums (PUM), and is debt-free. Universe 2: Net profit collapsed 67% in the same quarter because integrating a ₹412 crore acquisition (Paramount TPA) is like inviting a relative to stay “for a few days” who then stays for 18 months. Universe 3: The company’s AI is preventing ₹400 crore in fraud annually, but nobody’s paying for it yet. P/E of 39.4x on a company whose profits are playing hide-and-seek with growth. This is what “scaling” looks like when you’re bad at accounting for it.
02 — Introduction
The Boring Middleman In Healthcare Insurance (Who’s Actually Not Boring)
Imagine you’re an insurance company with 2 crore customers. Now imagine you don’t want to personally call them when they get admitted to a hospital, negotiate with doctors, process their claims, or handle the 100 other things that come with actually managing health insurance. So what do you do? You call Medi Assist. They’re the Third-Party Administrator (TPA) — basically, the hired help of the insurance world.
A TPA is what happens when an insurance company decides complexity is someone else’s problem. Medi Assist runs the whole show: processes 73 lakh claims a quarter, runs a 20,204-hospital network across 141 countries, manages ₹21,108 crore in premiums (PUM), and does it all for 32 insurance companies. They’re in group insurance (32.2% market share), retail insurance (5.6%), and government schemes (serving 33 crore members). It’s like being a hospital coordinator, claims auditor, fraud detective, and customer service representative — all at once, for one company.
They went from being a pure-play TPA to a health-tech company. Along the way, they acquired Medvantage (₹150 cr, Feb 2023), Raksha (₹150 cr, Aug 2023), and Paramount TPA (₹412 crore, July 2025). The idea: consolidate the fragmented TPA industry and become India’s largest. The execution: like a wedding where the caterer forgot half the ingredients but somehow the guests are still eating.
Management on Paramount (Feb 2026 Concall): “The Paramount drag has now come down to a fairly negligible amount at the EBITDA level.” Translation: It was losing ₹6.4% margin in Q2. Now it’s only losing 0.9%. This is what corporate optimism sounds like when you’ve invested ₹412 crore and are waiting for synergies to kick in.
03 — Business Model: What Do TPAs Even Do?
You’re Sick. Insurance Company Doesn’t Want To Deal With You. That’s Where They Come In.
Members get full access to every article.
